Intravital Imaging of Splenic Classical Monocytes Modifying the Hepatic CX3CR1 Cells Motility to Exacerbate Liver Fibrosis Via Spleen-liver Axis

Methods: The CX3CR1 transgenic mice and CX3CR1-KikGR transgenic mice were used to establish the CCl4-induced liver fibrosis model. Splenectomy, adoptive transfusion of splenocytes, photoconversion of splenic CX3CR1 cells and intravital imaging were performed to study the spatial distribution, migration and movement behavior, and regulatory function of CX3CR1 cells in liver fibrosis.

Results: Intravital imaging revealed that the CX3CR1 cells accumulated into the fibrotic liver and tended to accumulate towards the central vein (CV) in the hepatic lobules. Two subtypes of hepatic CX3CR1 cells existed in the fibrotic liver. The first subtype was the interacting CX3CR1 cells, most of which were observed to distribute in the liver parenchyma and had a higher process velocity; the second subtype was mobile CX3CR1 cells, most of which were present in the hepatic vessels with a faster moving speed. Splenectomy ameliorated liver fibrosis and decreased the number of CX3CR1 cells in the fibrotic liver. Moreover, splenectomy rearranged CX3CR1 cells to the boundary of the hepatic lobule, reduced the process velocity of interacting CX3CR1 cells and decreased the number and mobility of mobile CX3CR1 cells in the fibrotic liver. Transfusion of spleen-derived classical monocytes increased the process velocity and mobility of hepatic endogenous CX3CR1 cells and facilitated liver fibrosis progression via the production of proinflammatory and profibrotic cytokines. The photoconverted splenic CX3CR1 KikRed cells were observed to leave the spleen, accumulate into the fibrotic liver and contact with hepatic CX3CR1 KikGreen cells during hepatic fibrosis.

Conclusion: The splenic CX3CR1 monocytes with classical phenotype migrated from the spleen to the fibrotic liver, modifying the migratory behavior of hepatic endogenous CX3CR1 cells and exacerbating liver fibrosis via the secretion of cytokines. This study reveals that splenic CX3CR1 classical monocytes are a key driver of liver fibrosis via the spleen-liver axis and may be potential candidate targets for the treatment of chronic liver fibrosis.